# Aptar Pharma acquires SipNose's nasal drug delivery assets for $12.5M

US drug delivery company Aptar Pharma acquired the device technology assets of Israeli company SipNose Nasal Delivery Systems for approximately $12.5 million. SipNose, based in Yokneam, has developed a nasal drug delivery system for precise targeting of the nasal cavity.

- Type: Acquisition
- Announced: 2024-10-10
- Where: Yokneam, Israel, Israel
- Value: $12.5M
- Status: completed
- Products: nasal drug delivery system
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Aptar Pharma](https://endata.com/companies/1969.md) (acquirer)
- [SipNose Nasal Delivery Systems](https://endata.com/companies/80345.md) (target)

## Sources

- [en.globes.co.il](https://en.globes.co.il/en/article-aptar-pharma-buys-israeli-co-sipnose-1001491490), 2024-10-10: "This method is able to penetrate the Blood Brain Barrier through a breach discovered 20 years ago."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.